A detailed history of Calamos Advisors LLC transactions in Black Rock Health Sciences Trust stock. As of the latest transaction made, Calamos Advisors LLC holds 15,885 shares of BME stock, worth $632,223. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,885
Previous 5,764 175.59%
Holding current value
$632,223
Previous $210,000 181.43%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

BUY
$35.17 - $37.31 $355,955 - $377,614
10,121 Added 175.59%
15,885 $591,000
Q2 2025

Aug 08, 2025

SELL
$34.86 - $38.42 $25,308 - $27,892
-726 Reduced 11.19%
5,764 $210,000
Q1 2025

Apr 28, 2025

BUY
$37.49 - $41.0 $243,310 - $266,090
6,490 New
6,490 $250,000
Q3 2024

Nov 07, 2024

SELL
$39.94 - $42.41 $107,678 - $114,337
-2,696 Reduced 34.2%
5,188 $217,000
Q2 2024

Jul 25, 2024

BUY
$38.45 - $40.88 $96,125 - $102,200
2,500 Added 46.43%
7,884 $322,000
Q1 2024

May 08, 2024

BUY
$40.6 - $42.71 $218,590 - $229,950
5,384 New
5,384 $223,000

Others Institutions Holding BME

About BlackRock Health Sciences Trust


  • Ticker BME
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in r...
More about BME
Track This Portfolio

Track Calamos Advisors LLC Portfolio

Follow Calamos Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.